These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31788682)

  • 1. Metabolite Profiling of Ortho-, Meta- and Para-Fluorofentanyl by Hepatocytes and High-Resolution Mass Spectrometry.
    Gundersen POM; Åstrand A; Gréen H; Josefsson M; Spigset O; Vikingsson S
    J Anal Toxicol; 2020 Mar; 44(2):140-148. PubMed ID: 31788682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro metabolism of the novel synthetic opioid agonist cyclopropylfentanyl and subsequent confirmation in authentic human samples using liquid chromatography-high resolution mass spectrometry.
    Cutler C; Hudson S
    Drug Test Anal; 2019 Aug; 11(8):1134-1143. PubMed ID: 31081594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro and In Vivo Metabolite Identification Studies for the New Synthetic Opioids Acetylfentanyl, Acrylfentanyl, Furanylfentanyl, and 4-Fluoro-Isobutyrylfentanyl.
    Watanabe S; Vikingsson S; Roman M; Green H; Kronstrand R; Wohlfarth A
    AAPS J; 2017 Jul; 19(4):1102-1122. PubMed ID: 28382544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of a new synthetic opioid tetrahydrofuranylfentanyl in fresh isolated human hepatocytes: Detection and confirmation of ring-opened metabolites.
    Kanamori T; Segawa H; Yamamuro T; Kuwayama K; Tsujikawa K; Iwata YT
    Drug Test Anal; 2020 Apr; 12(4):439-448. PubMed ID: 31797567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS).
    Steuer AE; Williner E; Staeheli SN; Kraemer T
    Drug Test Anal; 2017 Jul; 9(7):1085-1092. PubMed ID: 27736030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Looking at flubromazolam metabolism from four different angles: Metabolite profiling in human liver microsomes, human hepatocytes, mice and authentic human urine samples with liquid chromatography high-resolution mass spectrometry.
    Wohlfarth A; Vikingsson S; Roman M; Andersson M; Kugelberg FC; Green H; Kronstrand R
    Forensic Sci Int; 2017 May; 274():55-63. PubMed ID: 27863836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotransformation of the New Synthetic Cannabinoid with an Alkene, MDMB-4en-PINACA, by Human Hepatocytes, Human Liver Microsomes, and Human Urine and Blood.
    Watanabe S; Vikingsson S; Åstrand A; Gréen H; Kronstrand R
    AAPS J; 2019 Dec; 22(1):13. PubMed ID: 31848852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Unique Metabolites of the Designer Opioid Furanyl Fentanyl.
    Goggin MM; Nguyen A; Janis GC
    J Anal Toxicol; 2017 Jun; 41(5):367-375. PubMed ID: 28369517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic characterization of AH-7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmation.
    Wohlfarth A; Scheidweiler KB; Pang S; Zhu M; Castaneto M; Kronstrand R; Huestis MA
    Drug Test Anal; 2016 Aug; 8(8):779-91. PubMed ID: 26331297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β'-Phenylfentanyl Metabolism in Primary Human Hepatocyte Incubations: Identification of Potential Biomarkers of Exposure in Clinical and Forensic Toxicology.
    Brunetti P; Lo Faro AF; Di Trana A; Montana A; Basile G; Carlier J; Busardò FP
    J Anal Toxicol; 2023 Jan; 46(9):e207-e217. PubMed ID: 36029472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo Metabolites of AB-PINACA in Solid Tissues Obtained from Its Abuser: Comparison with In Vitro Experiment.
    Minakata K; Hasegawa K; Yamagishi I; Nozawa H; Suzuki M; Kitamoto T; Suzuki O; Watanabe K
    J Anal Toxicol; 2021 Jan; 44(9):1027-1035. PubMed ID: 32232365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro Characterization of NPS Metabolites Produced by Human Liver Microsomes and the HepaRG Cell Line Using Liquid Chromatographyhigh Resolution Mass Spectrometry (LC-HRMS) Analysis: Application to Furanyl Fentanyl.
    Richeval C; Gicquel T; Hugbart C; Le Dare B; Allorge D; Morel I; Gaulier JM
    Curr Pharm Biotechnol; 2017; 18(10):806-814. PubMed ID: 29173157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of Carfentanil, an Ultra-Potent Opioid, in Human Liver Microsomes and Human Hepatocytes by High-Resolution Mass Spectrometry.
    Feasel MG; Wohlfarth A; Nilles JM; Pang S; Kristovich RL; Huestis MA
    AAPS J; 2016 Nov; 18(6):1489-1499. PubMed ID: 27495118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography-linear ion trap-mass spectrometry (LC-MS(n)).
    Meyer MR; Dinger J; Schwaninger AE; Wissenbach DK; Zapp J; Fritschi G; Maurer HH
    Anal Bioanal Chem; 2012 Jan; 402(3):1249-55. PubMed ID: 22065349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure Elucidation of Urinary Metabolites of Fentanyl and Five Fentanyl Analogs using LC-QTOF-MS, Hepatocyte Incubations and Synthesized Reference Standards.
    Wallgren J; Vikingsson S; Rautio T; Nasr E; Åstrand A; Watanabe S; Kronstrand R; Gréen H; Dahlén J; Wu X; Konradsson P
    J Anal Toxicol; 2021 Jan; 44(9):993-1003. PubMed ID: 32104892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of Fentanyl and Acetylfentanyl in Human-Induced Pluripotent Stem Cell-Derived Hepatocytes.
    Kanamori T; Togawa Iwata Y; Segawa H; Yamamuro T; Kuwayama K; Tsujikawa K; Inoue H
    Biol Pharm Bull; 2018; 41(1):106-114. PubMed ID: 29311471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicological Analysis of Fluorofentanyl Isomers in Postmortem Blood.
    Truver MT; Chronister CW; Kinsey AM; Hoyer JL; Goldberger BA
    J Anal Toxicol; 2022 Oct; 46(8):835-843. PubMed ID: 35277721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes.
    Gandhi AS; Wohlfarth A; Zhu M; Pang S; Castaneto M; Scheidweiler KB; Huestis MA
    Drug Test Anal; 2015 Mar; 7(3):187-98. PubMed ID: 24827428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of liquid chromatography-tandem mass spectrometry targeted screening of 16 fentanyl analogs and U-47700 in hair: Application to 137 authentic samples.
    Larabi IA; Martin M; Etting I; Pfau G; Edel Y; Alvarez JC
    Drug Test Anal; 2020 Sep; 12(9):1298-1308. PubMed ID: 32476263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmortem analysis of three methoxyacetylfentanyl-related deaths in Denmark and in vitro metabolite profiling in pooled human hepatocytes.
    Mardal M; Johansen SS; Davidsen AB; Telving R; Jornil JR; Dalsgaard PW; Hasselstrøm JB; Øiestad ÅM; Linnet K; Andreasen MF
    Forensic Sci Int; 2018 Sep; 290():310-317. PubMed ID: 30107329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.